ISOMETHEPTENE
Migraine Headache
Ache Laboratorios Farmaceuticos S.A.Small moleculePhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Migraine Headache cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NADOLOL Ohio University | Phase 4 | BBB |
Dihydroergotamine mesylate Impel Pharmaceuticals | Phase 3 | BB |
Capecitabine Ohio University | Phase 4 | BB |
DICLOFENAC Scripps Health | Phase 4 | BB |
Dfn-15 BioDelivery Sciences International | Phase 3 | BB |
View all 17 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →